tldrdailynews.com logo

Tirzepatide: The Promising Drug for Diabetes and Obesity Treatment.

1 min read
Source: CNN
Tirzepatide: The Promising Drug for Diabetes and Obesity Treatment.
Photo: CNN
TL;DR Summary

Eli Lilly and Company's injectable drug tirzepatide, currently approved for controlling blood sugar in people with type 2 diabetes, has been found to help patients lose weight as well. In a study of over 900 adults with obesity and diabetes, those on the highest dose lost an average of 34 pounds, or nearly 16% of their starting weight. The company plans to ask the FDA to fast-track approval for tirzepatide purely for weight loss, which would make it a direct competitor to the obesity drug Wegovy. Tirzepatide works by mimicking the action of two different gut hormones, and while it has been associated with more nausea, vomiting, and diarrhea, it has shown promising results in clinical trials.

Topics:business#diabetes#fda#health#obesity#tirzepatide#weight-loss
Share this article
  1. Blood sugar drug tirzepatide also leads to substantial weight loss in diabetes patients, Eli Lilly says  CNN
  2. New obesity drug Mounjaro poised to surpass Ozempic, Wegovy  The Associated Press
  3. Eli Lilly releases more data for new obesity drug, moving toward fast-track approval  NPR
  4. Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds  CNBC
  5. Tirzepatide Scores Win in Second Obesity Trial, SURMOUNT-2  Medscape

Reading Insights

Total Reads

0

Unique Readers

13

Time Saved

3 min

vs 4 min read

Condensed

83%

693 → 117 words

Want the full story? Read the original article

Read on CNN